Table 5.
Liver disease score | Baseline |
Duration of follow-up |
|||
4 wk | 3 mo | 6 mo | 1 yr | ||
Maddrey DF score | |||||
Group I1 | 54.25 ± 16.24 | 23.29 ± 12.07 | 14.3 ± 4.53 | 10.24 ± 4.27 | 7.79 ± 3.2 |
Group II2 | 57.78 ± 17.08 | 27.82 ± 11.73 | 15.60 ± 6.21 | 11.16 ± 3.70 | 7.27 ± 2.67 |
P value | 0.39 | 0.15 | 0.39 | 0.43 | 0.94 |
MELD Score | |||||
Group I1 | 23.14 ± 3.97 | 15.53 ± 3.63 | 12.41 ± 2.88 | 10.37 ± 2.32 | 9.18 ± 1.59 |
Group II2 | 22.65 ± 3.33 | 17.78 ± 4.56 | 13.45 ± 2.77 | 11.14 ± 1.83 | 9.4 ± 1.88 |
P value | 0.58 | 0.04 | 0.20 | 0.21 | 0.67 |
GAHS | |||||
Group I1 | 8.23 ± 1.07 | 6.37 ± 0.79 | 6.10 ± 0.77 | 5.96 ± 0.90 | 5.74 ± 0.66 |
Group II2 | 7.94 ± 0.95 | 6.52 ± 1.09 | 5.91 ± 0.61 | 5.91 ± 0.61 | 5.7 ± 0.57 |
P value | 0.24 | 0.56 | 0.34 | 0.81 | 0.83 |
Child’s score | |||||
Group I1 | 11.85 ± 1.62 | 9.69 ± 2.57 | 7.14 ± 1.60 | 5.96 ± 1.09 | 5.78 ± 0.89 |
Group II2 | 12.15 ± 1.28 | 9.81 ± 2.08 | 7.59 ± 1.68 | 6.23 ± 0.97 | 5.9 ± 0.79 |
P value | 0.41 | 0.84 | 0.33 | 0.38 | 0.63 |
P < 0.05 considered statistically significant.
In group I: n = 34 at baseline, n = 32 at 4 wk and n = 29 at 3 mo, n = 27 at 6 mo and 1 year.
In group II: n = 34 at baseline, n = 27 at 4 wk and n = 22 at 3 mo, 6 mo and n = 20 at 1 year.